Skip to main content

Health & Medicine

Medisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical Compounding

This partnership brings together EUROAPI’s European pharmaceutical manufacturing capabilities and Medisca’s compounding expertise to expand access, strengthen its API portfolio and advance collaboration in peptides. MONTREAL — Medisca and EUROAPI have formed a strategic partnership focused on expanding API access for pharmaceutical compounding, creating differentiated access in North America and…

financialpost.com ·4h ago

Medisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical Compounding

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Health & Medicine

First Ebola case revives debate over Nanyuki quarantine centre

Residents of Nanyuki are renewing calls for clarity over the controversial Ebola quarantine facility at Laikipia Air Base, asking whether it will be available to Kenyans if the virus reaches Laikipia.

4h ago ·peopledaily.digital

Sudan faces epidemic crisis as war and rainfall converge

Sudan's health crisis deepens as war ravages the nation, with citizens facing the dual threats of conflict and deadly diseases like malaria and dengue.

4h ago ·iol.co.za

Delta Expands Breast Cancer Fight As Partnership Hits $36m

A Delta Airline Staff Delta Air Lines has expanded its commitment to breast cancer research after raising $36 million with the Breast Cancer Research Foundation (BCRF) over more than Read More...

4h ago ·dailyguidenetwork.com

Gene expression linked to survival differs by kidney cancer subtype

Renal cell carcinoma (RCC) is the most common form of kidney cancer, accounting for about 90% of kidney cancers. It develops when abnormal cells in the kidney's small tubules begin to grow…

4h ago ·medicalxpress.com

Menopause drug Lenzetto returns to Spanish pharmacies in November

Gedeon Richter has told Euronews it expects this menopause treatment to be available again in Spain from mid-November, but warns that global limits could stop it meeting demand in 2027.

Lenzetto returns to Spanish pharmacies November from shortage
Gedeon Richter increasing production, seeking new suppliers
European Medicines Agency and Spanish health ministry reviewing coordinated measures

4h ago ·euronews.com

Menopause drug Lenzetto back in Spanish pharmacies from November

Gedeon Richter has told Euronews it expects to restore availability of this menopause treatment in Spain from the second half of November, but warns global restrictions may prevent it from meeting…

4h ago ·euronews.com

More from Wednesday 7 October →